Citation: | XU Jiaxuan, ZUO Yifan, SUN Jingjing, CHEN Bing. Prognostic Analysis of Socioeconomic Factors in Multiple Myeloma Patients and Construction of A Myeloma-specific Survival Prediction Model[J]. Cancer Research on Prevention and Treatment, 2023, 50(4): 370-377. DOI: 10.3971/j.issn.1000-8578.2023.22.1075 |
To investigate the effects of socioeconomic factors on the prognosis of multiple myeloma (MM) patients and construct a prediction model for evaluating myeloma-specific survival (MSS) rates.
A total of 32625 patients diagnosed with MM between January 2007 and December 2016 were included through the SEER database. Cox regression model was used to analyze the predictive indicators of MSS. The results of the multivariate subgroup analysis were presented as forest plots. The significant factors identified in the multivariate Cox analysis were used to construct a nomogram. The predictive performance of the nomogram was assessed using the AUC and calibration plots. A nomogram score-based risk stratification system was constructed using a restricted cubic spline.
Patients were divided into five groups according to their socioeconomic status (SES). Groups with higher SES had relatively higher proportions of those part of the White, insured, married, and urban populations. Age, gender, race, marital status, insurance status, and SES were independent prognostic factors of MSS (all P < 0.001). The linear trend of increased MSS risk with decreasing SES was most pronounced among the White, married, insured, and urban patients (all P < 0.001). The nomogram exhibited good discrimination and accuracy in both training and validation sets, showing AUC values of 0.701, 0.709, and 0.722 for predicting 3-, 5-, and 8-year MSS, respectively. A risk stratification model was established based on the nomogram total points and the HR, which then divided patients into three different risk levels with substantial survival disparities (all P < 0.001).
Socioeconomic factors, such as marital status, insurance status, and SES, have a significant impact on the survival outcomes of MM patients. The nomogram and the risk stratification model based on these factors can accurately and reliably predict MSS.
Competing interests: The authors declare that they have no competing interests.
[1] |
Kumar SK, Rajkumar V, Kyle RA, et al. Multiple myeloma[J]. Nat Rev Dis Primers, 2017, 3: 17046. doi: 10.1038/nrdp.2017.46
|
[2] |
Liu J, Liu W, Mi L, et al. Incidence and mortality of multiple myeloma in China, 2006-2016: an analysis of the Global Burden of Disease Study 2016[J]. J Hematol Oncol, 2019, 12(1): 136. doi: 10.1186/s13045-019-0807-5
|
[3] |
Pulte D, Jansen L, Brenner H. Changes in long term survival after diagnosis with common hematologic malignancies in the early 21st century[J]. Blood Cancer J, 2020, 10(5): 56. doi: 10.1038/s41408-020-0323-4
|
[4] |
Fonseca R, Abouzaid S, Bonafede M, et al. Trends in overall survival and costs of multiple myeloma, 2000-2014[J]. Leukemia, 2017, 31(9): 1915-1921. doi: 10.1038/leu.2016.380
|
[5] |
Sun T, Wang S, Sun H, et al. Improved survival in multiple myeloma, with a diminishing racial gap and a widening socioeconomic status gap over three decades[J]. Leuk Lymphoma, 2018, 59(1): 49-58. doi: 10.1080/10428194.2017.1335398
|
[6] |
Costa LJ, Brill IK, Brown EE. Impact of marital status, insurance status, income, and race/ethnicity on the survival of younger patients diagnosed with multiple myeloma in the United States[J]. Cancer, 2016, 122(20): 3183-3190. doi: 10.1002/cncr.30183
|
[7] |
Fiala MA, Finney JD, Liu J, et al. Socioeconomic status is independently associated with overall survival in patients with multiple myeloma[J]. Leuk Lymphoma, 2015, 56(9): 2643-2649. doi: 10.3109/10428194.2015.1011156
|
[8] |
Makhani SS, Shively D, Castro G, et al. Association of insurance disparities and survival in adults with multiple myeloma: A non-concurrent cohort study[J]. Leuk Res, 2021, 104: 106542. doi: 10.1016/j.leukres.2021.106542
|
[9] |
Tang L, Pan Z, Zhang X. The effect of marital status on the survival of patients with multiple myeloma[J]. Hematology, 2022, 27(1): 187-197. doi: 10.1080/16078454.2022.2026027
|
[10] |
Intzes S, Symeonidou M, Zagoridis K, et al. Socioeconomic Status Is an Independent Prognostic Factor for Overall Survival in Patients With Multiple Myeloma: Real-World Data From a Cohort of 223 Patients[J]. Clin Lymphoma Myeloma Leuk, 2020, 20(10): 704-711. doi: 10.1016/j.clml.2020.05.013
|
[11] |
Castañeda-Avila MA, Jesdale BM, Beccia A, et al. Differences in survival among multiple myeloma patients in the United States SEER population by neighborhood socioeconomic status and race/ethnicity[J]. Cancer Causes Control, 2021, 32(9): 1021-1028. doi: 10.1007/s10552-021-01454-w
|
[12] |
Chamoun K, Firoozmand A, Caimi P, et al. Socioeconomic Factors and Survival of Multiple Myeloma Patients[J]. Cancers (Basel), 2021, 13(4): 590. doi: 10.3390/cancers13040590
|
[13] |
Intzes S, Symeonidou M, Zagoridis K, et al. Socioeconomic Status is Globally a Prognostic Factor for Overall Survival of Multiple Myeloma Patients: Synthesis of Studies and Review of the Literature[J]. Mediterr J Hematol Infect Dis, 2021, 13(1): e2021006.
|
[14] |
Collins GS, Reitsma JB, Altman DG, et al. Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement[J]. Ann Intern Med, 2015, 162(1): 55-63. doi: 10.7326/M14-0697
|
[15] |
Harwood M, Dunn N, Moore J, et al. Trends in myeloma relative survival in Queensland by treatment era, age, place of residence, and socioeconomic status[J]. Leuk Lymphoma, 2020, 61(3): 721-727. doi: 10.1080/10428194.2019.1688322
|
[16] |
Yu M, Tatalovich Z, Gibson JT, et al. Using a composite index of socioeconomic status to investigate health disparities while protecting the confidentiality of cancer registry data[J]. Cancer Causes Control, 2014, 25(1): 81-92. doi: 10.1007/s10552-013-0310-1
|
[17] |
Xu L, Wang X, Pan X, et al. Education level as a predictor of survival in patients with multiple myeloma[J]. BMC Cancer, 2020, 20(1): 737. doi: 10.1186/s12885-020-07178-5
|
[18] |
Boen CE, Barrow DA, Bensen JT, et al. Social Relationships, Inflammation, and Cancer Survival[J]. Cancer Epidemiol Biomarkers Prev, 2018, 27(5): 541-549. doi: 10.1158/1055-9965.EPI-17-0836
|
[19] |
Freeman A, Tyrovolas S, Koyanagi A, et al. The role of socio-economic status in depression: results from the COURAGE (aging survey in Europe)[J]. BMC Public Health, 2016, 16(1): 1098. doi: 10.1186/s12889-016-3638-0
|
[20] |
Bortolato B, Hyphantis TN, Valpione S, et al. Depression in cancer: The many biobehavioral pathways driving tumor progression[J]. Cancer Treat Rev, 2017, 52: 58-70. doi: 10.1016/j.ctrv.2016.11.004
|
[21] |
Kruk J, Aboul-Enein BH, Bernstein J, et al. Psychological Stress and Cellular Aging in Cancer A Meta-Analysis[J]. Oxid Med Cell Longev, 2019, 2019: 1270397.
|